Literature DB >> 6175230

Structural requirements for action of cholecystokinin on enzyme secretion from pancreatic acini.

M L Villanueva, S M Collins, R T Jensen, J D Gardner.   

Abstract

Using dispersed acini prepared from guinea pig pancreas, we found that the structural requirements for cholecystokinin-induced stimulation of amylase secretion are the same as those for cholecystokinin-induced desensitization of amylase secretion. 1) The relative potencies with which various C-terminal fragments of cholecystokinin cause stimulation are the same as their relative potencies for causing desensitization. 2) With each fragment tested, desensitization occurs with peptide concentrations that are supramaximal for causing stimulation of amylase secretion. 3) Fragments of cholecystokinin less efficacious in causing supramaximal inhibition of amylase secretion are also less efficacious in causing desensitization of amylase secretion. In contrast, there is no obvious fixed relation between the ability of a cholecystokinin fragment to cause stimulation of enzyme secretion and its ability to cause residual stimulation of enzyme secretion. Cholecystokinin and its C-terminal hexadecapeptide are 25-40% more efficacious than the C-terminal decapeptide, octapeptide, and heptapeptide in causing residual stimulation, and the C-terminal pentapeptide and tetrapeptide caused no detectable residual stimulation. The C-terminal tetrapeptide, however, can prevent as well as reverse the residual stimulation caused by other cholecystokinin fragments, and the ability of the tetrapeptide to prevent cholecystokinin-induced residual stimulation is itself fully reversible.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175230     DOI: 10.1152/ajpgi.1982.242.4.G416

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  The Src kinase Yes is activated in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters, but not pancreatic growth factors, which stimulate its association with numerous other signaling molecules.

Authors:  Veronica Sancho; Bernardo Nuche-Berenguer; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2012-05-19

2.  PKCθ activation in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors is needed for stimulation of numerous important cellular signaling cascades.

Authors:  Veronica Sancho; Marc J Berna; Michelle Thill; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2011-07-23

3.  Inhibition of acid formation and stimulation of somatostatin release by cholecystokinin-related peptides in rabbit gastric glands.

Authors:  P Bengtsson; G Lundqvist; G Nilsson
Journal:  J Physiol       Date:  1989-12       Impact factor: 5.182

4.  Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion.

Authors:  A K Saluja; M Saluja; H Printz; A Zavertnik; A Sengupta; M L Steer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Bioactivity of synthetic human cholecystokinin (CCK)-33 in vitro and in vivo.

Authors:  H Shinozaki; K Miyasaka; H Wakasugi; N Fujii; A Funakoshi
Journal:  Gastroenterol Jpn       Date:  1991-02

6.  Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer.

Authors:  I R Swift; J P Smith
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

7.  Cholecystokinin-octapeptide constricts guinea-pig and human airways.

Authors:  C D Stretton; P J Barnes
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

8.  Rapid down-regulation of substance P binding to guinea-pig pancreatic acinar cells during homologous desensitization.

Authors:  L Sjödin; E Viitanen; E Gylfe
Journal:  J Physiol       Date:  1994-04-01       Impact factor: 5.182

9.  Comparison of hepatic elimination of different forms of cholecystokinin in dogs. Bioassay and radioimmunoassay comparisons of cholecystokinin-8-sulfate and -33-sulfate.

Authors:  T Sakamoto; M Fujimura; J Newman; X G Zhu; G H Greeley; J C Thompson
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

10.  Vagal control of satiety and hormonal regulation of appetite.

Authors:  Chung Owyang; Andrea Heldsinger
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.